Interindividual variation in the metabolism of ethynylestradiol. 1989

M L Orme, and D J Back, and S Ball
Department of Pharmacology and Therapeutics, University of Liverpool, U.K.

UI MeSH Term Description Entries
D007206 Individuality Those psychological characteristics which differentiate individuals from one another. Individual Differences,Difference, Individual,Differences, Individual,Individual Difference
D004997 Ethinyl Estradiol A semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES. 19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17alpha)-,Ethynyl Estradiol,Estinyl,Ethinyl Estradiol Hemihydrate,Ethinyl Estradiol, (8 alpha)-Isomer,Ethinyl Estradiol, (8 alpha,17 alpha)-Isomer,Ethinyl Estradiol, (8 alpha,9 beta,13 alpha,14 beta)-Isomer,Ethinyl Estradiol, (9 beta,17 alpha)-Isomer,Ethinyl-Oestradiol Effik,Ethinylestradiol Jenapharm,Ethinyloestradiol,Lynoral,Microfollin,Microfollin Forte,Progynon C,Estradiol, Ethinyl,Estradiol, Ethynyl,Ethinyl Oestradiol Effik,Hemihydrate, Ethinyl Estradiol,Jenapharm, Ethinylestradiol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.

Related Publications

M L Orme, and D J Back, and S Ball
January 1986, Progress in clinical and biological research,
M L Orme, and D J Back, and S Ball
November 1992, Environmental health perspectives,
M L Orme, and D J Back, and S Ball
July 1979, Xenobiotica; the fate of foreign compounds in biological systems,
M L Orme, and D J Back, and S Ball
December 2004, Toxicology and applied pharmacology,
M L Orme, and D J Back, and S Ball
January 1984, IARC scientific publications,
M L Orme, and D J Back, and S Ball
April 2000, Journal of clinical psychopharmacology,
M L Orme, and D J Back, and S Ball
February 2001, Xenobiotica; the fate of foreign compounds in biological systems,
M L Orme, and D J Back, and S Ball
May 1996, Clinical and experimental dermatology,
M L Orme, and D J Back, and S Ball
December 2004, Toxicology letters,
M L Orme, and D J Back, and S Ball
January 1983, Scandinavian journal of infectious diseases,
Copied contents to your clipboard!